Cargando…
TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection
Tumour antigens have attracted much attention because of their importance to cancer diagnosis, prognosis and targeted therapy. With the development of cancer genomics, the identification of tumour-specific neoantigens became possible, which is a crucial step for cancer immunotherapy. In this study,...
Autores principales: | Zhou, Zhan, Lyu, Xingzheng, Wu, Jingcheng, Yang, Xiaoyue, Wu, Shanshan, Zhou, Jie, Gu, Xun, Su, Zhixi, Chen, Shuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414268/ https://www.ncbi.nlm.nih.gov/pubmed/28484631 http://dx.doi.org/10.1098/rsos.170050 |
Ejemplares similares
-
TSNAD v2.0: A one-stop software solution for tumor-specific neoantigen detection
por: Zhou, Zhan, et al.
Publicado: (2021) -
TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis
por: Wu, Jingcheng, et al.
Publicado: (2018) -
DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity
por: Wu, Jingcheng, et al.
Publicado: (2019) -
Mutation-profile-based methods for understanding selection forces in cancer somatic mutations: a comparative analysis
por: Zhou, Zhan, et al.
Publicado: (2017) -
TSNAdb v2.0: The Updated Version of Tumor-specific Neoantigen Database
por: Wu, Jingcheng, et al.
Publicado: (2023)